logo-loader
viewPreveCeutical Medical Inc.

PreveCeutical Medical gets first Aurora cannabis shipment

Earlier this month, the firm said it had received the key permits to allow this material to be imported into Australia

cannabis plants
The firm said it had received the first shipment of dried cannabis flower and oils

PreveCeutical Medical Inc (CSE:PREV, OTCQB:PRVCF) said it had received the first shipment of dried cannabis flower and oils from Aurora Cannabis, which means soluble gel (Sol-gel) delivery testing can now start.

As revealed earlier this month, the firm, in a major milestone, had received the key permits to allow this material to be imported into Australia by the  cannabis major.

It will be used for the group's research led by Preveceutical's chief research officer Dr Harendra Parekh at the University of Queensland.

"Testing of the imported cannabis strains in the application of soluble gel (Sol-gel) drug-delivery technology to cannabinoids is now expected to commence," said the firm in a brief statement.

"The purpose of the testing will be to develop therapies for relief from a range of symptoms, including pain, inflammation, seizures and neurological disorders."

The advantages of Sol-gels over conventional liquid nasal sprays include reduced dosage requirements, and reduced irritation and other negative side effects.

Shares in the group shed 1.35% to stand at C$0.36 each.

Quick facts: PreveCeutical Medical Inc.

Price: 0.015 CAD

CSE:PREV
Market: CSE
Market Cap: $5.95 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of PreveCeutical Medical Inc. named herein, including the promotion by the Company of PreveCeutical Medical Inc. in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Preveceutical announces successful preliminary evaluation of...

Preveceutical (CSE:PREV-OTCQB: PRVCF) President Mak Jawadeker joined Steve Darling from Proactive Vancouver on Skype to discuss the company successfully completing the design, synthesis and preliminary evaluation of key peptides from its scorpion venom-derived peptide research and development...

3 weeks, 2 days ago

2 min read